Needle and syringe programmes

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Needle and syringe programmes (NSPs) are public health initiatives that aim to reduce the spread of infectious diseases, particularly HIV and hepatitis C, among intravenous drug users. These programmes provide sterile needles and syringes to individuals who inject drugs, in an effort to prevent the sharing and reuse of injection equipment, which can transmit these diseases.

History[edit | edit source]

The first NSP was established in Amsterdam in 1984, in response to concerns about the spread of HIV among the city's drug-using population. The success of this programme led to the establishment of similar initiatives in other countries, including the United Kingdom, Australia, and the United States.

Effectiveness[edit | edit source]

Numerous studies have demonstrated the effectiveness of NSPs in reducing the spread of infectious diseases. A 2012 review by the World Health Organization found that NSPs significantly reduce HIV transmission and do not increase drug use. Similarly, a 2014 review in the British Medical Journal concluded that NSPs are associated with decreases in the prevalence of hepatitis C.

Criticism and controversy[edit | edit source]

Despite their demonstrated effectiveness, NSPs have been the subject of controversy. Critics argue that these programmes condone and enable drug use. However, proponents of NSPs argue that they are a pragmatic response to a public health issue, and that they can serve as a bridge to other services, such as drug treatment and counseling.

See also[edit | edit source]



   This article is a Public health stub. You can help WikiMD by expanding it!





This harm reduction related article is a stub. You can help WikiMD by expanding it.



This drug policy related article is a stub. You can help WikiMD by expanding it.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD